Interestingly, in this cohort of patients, the number of tumor-infiltrating CD8+, CD68+, and the CD68+/CD8 + ratio did not differ in invasive and non-invasive tumors and with the overall outcome of the disease. Here, CD68 is linked to neoplasm.